by Gothami Samaraweera - Research Assistant | SEO Content Writer | Health and Wellness | Mar 21, 2026 | Zepbound
Tirzepatide is one of the newest medications in the GLP-1 weight loss landscape. The U.S. Food and Drug Administration (FDA) approved it in November 2023 for adults with obesity or those who are overweight with weight-related health conditions. Zepbound became the...
